St. Josefskrankenhaus Heidelberg GmbH

At St. Josefskrankenhaus Heidelberg GmbH, clinical research in cardiovascular disease focuses on understanding and reducing major heart and vessel-related events in people with high-risk conditions. The studies explore whether new treatment combinations or targeted therapies can better protect patients with atherosclerotic cardiovascular disease, hypertension, and related complications.

• Testing new approaches to lower the risk of heart attack, stroke, and other major cardiovascular events
• Evaluating treatments for people with established cardiovascular disease and elevated risk profiles
• Studying therapies aimed at improving outcomes in patients with elevated Lp(a) and inflammatory cardiovascular conditions

This work includes efforts to improve treatment effectiveness and long-term protection for patients with complex heart and circulation disorders.

The Klinisches Studienzentrum in Heidelberg is also active in research on metabolic disease, especially type 2 diabetes mellitus and its links to kidney and cardiovascular complications. These trials are designed to assess whether newer therapies can better control disease-related risks and improve outcomes in patients with multiple chronic conditions.

• Investigating treatments for type 2 diabetes with high cardiovascular risk
• Studying kidney-related complications in diabetes, including chronic kidney disease
• Comparing treatment strategies to reduce cardiovascular and renal burden in metabolically complex patients

The overall goal is to find more effective ways to manage diabetes while also addressing heart and kidney health.

Research in skin and connective tissue diseases at this site includes studies focused on difficult-to-treat chronic venous ulcers. These trials are examining whether new topical therapies can support wound healing and improve safety compared with standard or placebo-based care.

• Assessing therapies for persistent chronic venous ulcers
• Evaluating wound closure as a key sign of treatment benefit
• Exploring new local treatments intended to improve healing in therapy-resistant ulcers

This research aims to advance care for patients living with long-lasting wounds that can be difficult to heal and manage.